MoH, ACC and general health policies are founded upon international and local research evidence that people respond best when cared for within their own communities.
LFTI’s focus must be compatible with Crown Health policies and provide financially sustainable service offerings which will complement the services offered by larger organisations under Crown Agency contracts. This approach is expected to involve both collaborative initiatives and stand-alone projects in order to assist disabled persons to achieve their potential and independence in daily living and fulfil our other Constitutional objectives.
The new Ministry for Disabled People and new funding policy announced 29 October 2021 to reform disability services and improve accessibility has promised to provide disabled persons with increased discretion to manage how their disability budget is spent.
- This methodology, called “Enabling Good Lives” has been trialled in Waikato, Mid Central and Canterbury DHB’s for about six years and has been shown in multiple instances to produce significantly better outcomes without increased cost. These better outcomes are for the disabled person, whanau, and social and economic costs associated with disability across, variously, the Ministries of Education, Health, Justice and Social Development.
- The approach is a founding principle of Manawanui which has been New Zealand’s leading provider of Individualised Funding Services since 2004.
- The LFTI/Autism NZ co-venture enables the parties to take an individualised funding project as the test case for future activities
The co-venture has three objectives:
- To provide LFTI with a proven path of assistance to disabled persons under the new Ministry policy of self-directed funding
- To accelerate understanding of that proven path by joining with a worthy project which is already well advanced but where LFTI can make a critical contribution and thereby take advantage of work already completed
- To provide evidence of a methodology consistent with the new Ministry policy which may be applied to a wider range of neurological disorders and neurodivergent conditions for which materially improved outcomes are known to be available from early identification and support.